NovMetaPharma Co (XKRX:229500) EV-to-FCF : -19.93 (As of Apr. 18, 2025)

NovMetaPharma Co EV-to-FCF Chart

NovMetaPharma Co Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-FCF		Get a 7-Day Free Trial					-41.75	-39.90	-28.29	-39.57	-10.81

NovMetaPharma Co Semi-Annual Data
	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-FCF	Get a 7-Day Free Trial					-41.75	-39.90	-28.29	-39.57	-10.81

Competitive Comparison of NovMetaPharma Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, NovMetaPharma Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NovMetaPharma Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NovMetaPharma Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where NovMetaPharma Co's EV-to-FCF falls into.

NovMetaPharma Co EV-to-FCF Calculation

NovMetaPharma Co's EV-to-FCF for today is calculated as:

NovMetaPharma Co's current Enterprise Value is ₩103,036.62 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NovMetaPharma Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-5,170.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NovMetaPharma Co  (XKRX:229500) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

NovMetaPharma Co's PE Ratio (TTM) for today is calculated as:

NovMetaPharma Co's share price for today is ₩8480.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NovMetaPharma Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-504.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

NovMetaPharma Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of NovMetaPharma Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

NovMetaPharma Co Business Description